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ABSTRACT 
Objective: The objective of the present work is to develop and validate a novel, specific, precise and reliable method for estimation of Capecitabine in bulk and pharmaceutical dosage form using UV-visible spectroscopy and RP-HPLC method.  
Methods: UV-visible spectrophotometric determination was performed with Elico double beam SL 210 UV-visible spectrophotometer having deuterium lamp at λmax 304 nm using water as a medium. Linearity was noted over a concentration range of 2-20 µg/ml with a correlation 
coefficient of 0.99. HPLC analysis was performed using Eclipse XDB C18 column with 5 µm particle size having dimensions 4.6 X 250 mm column, 
Agilent 1260 infinity DAD detector, 1260 infinity quaternary pump using Ezchrome software at a flow rate of 1 ml/min and a run time pressure of 
2140 psi. Methanol: acetonitrile: water in the ratio 30: 30: 40 was used as mobile phase and the effluents were analyzed at 304 nm. Both the proposed methods were validated for various parameters like linearity, precision, accuracy, robustness, ruggedness, selectivity, detection, 
quantification limits, formulation analysis as per International Conference on Harmonization (ICH) guidelines.  
Results: Linearity for UV and HPLC method was noted over a concentration range of 2-100 µg/ml with a correlation coefficient of 0.99. The 
retention time was considered to be 4.60 min. The % RSD for interday and intraday precision studies and recovery analysis of both UV and HPLC methods was found to be less than 1% which is less than the official RSD limit (2%). Recovery analysis performed using marketed formulation capeguard was considered to be greater than 99% for both the methods.  
Conclusion: Both the methods developed were validated according to the ICH guidelines. Hence it was evident that the developed methods were novel, sensitive, precise and reliable for estimation of Capecitabine in bulk and were successfully applied for estimation of pharmaceutical dosage forms. 
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INTRODUCTION Capecitabine (CPTB) is a new, orally administered, enzyme-activated fluoropyrimidine carbamate belonging to the class antimetabolites. The drug is official in the Indian Pharmacopoeia (IP)[1, 2]. The chemical name of Capecitabine is 5-deoxy-5-fluoro-N-(pentyloxy) carbonyl]–cytidine with a molecular formula C15H22FN3O6 and 
molecular weight 359.35[3, 4]. The chemical structure is intended to generate high levels of fluorouracil (5-FU) in tumor cells located in the colorectal and breast region. Capecitabine is a prodrug of 5-
deoxy-5-fluorouridine (5-DFU), which undergoes enzymatic conversion to be 5-fluorouracil [5-FU] in tumor cells [5, 6]. The 5-FU inhibits the synthesis of thymidine monophosphate, which is an 
active form of thymidine required for de novo synthesis of Deoxy Ribo Nucleic acid [7-10]. The empirical formula of the functional moiety is C15H22FN3O6. The active moiety acts by mimicking as a normal cell nutrient which is indispensable to the growth of cancer cells. Literature survey disclosed that there are few analytical methods for spectrophotometric [11] and chromatographic estimation of capecitabine [12-16].  A detailed review of the literature regarding the existing methods revealed that there is a need for the development of the spectrophotometric method and chromatographic method, which is simple with less time tedious mobile phase or dilution medium. In the present study modest, novel, sensitive, reliable and accurate methods have been established for the estimation of capecitabine in bulk and in tablet dosage forms. Both the methods have a simple medium like water or feasible mobile phase mixture, which can be used for analysis of capecitabine with better separation of analytes. An attempt was made in the present methods to achieve an accurate, reliable and reproducible result with minimum Relative Standard Deviation (RSD) values than all other existing methods, which was successfully accomplished.  
MATERIALS AND METHODS 
Chemicals and reagents The reference sample capecitabine (CPTB) was secured from Torrent Pharmaceuticals Limited. Ahmedabad. All the reagents used stood at analytical grade. Acetonitrile (HPLC grade) and triethylamine (HPLC 
grade) were acquired from Merck pharmaceutical's private ltd., Mumbai, 
India. Methanol and water used were of HPLC grade and purchased from 
Merck specialty's private ltd., Mumbai, India. Commercial tablet CAPEGUARD was procured from the local market. 
Instrument specifications The UV analysis was performed using Elico double beam SL 210 UV-visible spectrophotometer having deuterium lamp associated with spectra treats software.  The HPLC analysis was performed using agilent 1260 infinity system (Ezchrome elite software) consisting of 
DAD VL detector adjusted to a wavelength of 304 nm. The instrument also consisted of an eclipse XDB model C18 column (5 µm particle size, 
4.6 x 250 mm) and a 1260 infinity VL quaternary pump.  
Spectrophotometric and chromatographic conditions Spectrophotometric analysis was performed using triple distilled water as mobile phase. The detection was carried out at an 
absorption maximum (λmax) of 304 nm. Chromatographic separation was achieved using mobile phase methanol: acetonitrile: water at a ratio 30: 30: 40. A flow rate of 1 ml/min was maintained throughout the separation process. Run time 
pressure of 2140 psi was maintained. All the contents of the mobile 
phase were filtered through a 0.45 mm membrane filter and degassing was performed using ROHS sonicator to remove dissolved gases if any. For each trial, 20 µl samples were injected manually, and a total run time 
of 6 min was maintained. The eluent was detected at 304 nm. Various systems suitability parameters were assessed as mentioned in table 1. 
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Table 1: System suitability parameters for HPLC 
S. No. Parameter Results 1 Standard concentration 1 mg/ml 2 Mobile phase 30:30:40 Methanol: acetonitrile: water 
3 Elution Isocratic  
4 Wavelength 304 nm 5 Column Eclipse XDB C18  
6 Detector  DAD PDI detector 7 Flow rate 1 ml/min 8 Column Volume 1322.5 mm3 9 Run time pressure 2140 psi 10 Retention time 4.6 min 11 Runtime 6 min 12 Peak area 4438704.660 
13 Tailing factor 0.941 
14 Peak Asymmetry Factor 0.882 15 Column dead time 1322.5 min 
16 Purging valve pressure 140 psi 
 
Preparation of stock solutions and sample solutions For the spectrophotometric analysis stock solutions of CPTB was prepared by dissolving 10 mg of the drug in 10 ml distilled water to obtain a final concentration of 1 mg/ml. Serial dilutions were made to prepare diverse sample solutions of concentrations ranging from 2–20 µl/ml. The solutions were analyzed at an absorption maximum of 304 nm against the blank. For chromatographic analysis of CPTB, the stock solution was prepared by dissolving 10 mg of the drug in 10 ml of the mobile phase to obtain a final concentration of 1 mg/ml. Serial dilutions were made to obtain sample solutions of concentrations ranging from 2–100 µl/ml. All the sample solutions were filtered through 0.45 mm membrane filters and were subjected to degassing. The sample 
solutions were analyzed at an absorption maximum of 304 nm. 
Validation of developed methods [17-19] 
Linearity and range Linearity is defined as the ability to obtain test results, which were directly proportional with the concentration of an analyte in the sample within a given range.  Linearity data for the spectrophotometric method was obtained at 
an absorption maxima of 304 nm as shown in fig. 1 by using ten concentrations in the range of 2–20 µg/ml. Calibration curve was obtained by plotting absorbance against concentration by 
considering six observations as shown in fig. 2. Linearity data for the chromatographic method was obtained by using ten concentrations within the range of 2–100 µg/ml. Calibration curve was obtained plotting peak area against concentration by considering five observations as shown in fig. 3. 
Both the methods were studied using six replicates of each sample concentrations. 
Precision The degree of closeness of agreement between a series of measurements obtained from multiple samplings of the same homogeneous sample under the prescribed condition was determined. The intra-day precision was performed by analyzing six replicate standard solutions on the same day, and inter-day precision was performed by analyzing a series of standard solutions 
for 3 consecutive days using the proposed UV and HPLC methods. The data obtained was presented in table 5. 
Robustness Robustness is defined as the measure of its capacity to remain unaffected by small but deliberate variation in method parameters, and it provides an indication to its reliability during normal range. Robustness of both 
the methods was studied using six replicates of the sample at a 
concentration level of 60 µg/ml (for HPLC) and 10 µg/ml (for UV). 
Ruggedness Ruggedness was calculated by considering the same sample at different labs by different analysts. 
Detection and quantification limits Limit of detection (LOD) represents the lowest amount of analyte in the sample which can be detected.  
Limit of quantification (LOQ) represents the lowest amount of analyte, which can be quantitatively determined. The above parameters are calculated based on the standard deviation of the response and the slope. The standard deviation was calculated based upon the calibration curve. 
LOD = 3.3σ/SLOQ = 10σ/S 
Selectivity and specificity The ability to measure accurately and specifically the analyte of interest 
in the presence of other components like excipients in the tablet formulation was analyzed. The blank, standard, placebo, placebo along with analyte and test preparations were analyzed as per the method to identify interference of blank and placebo with CPTB peaks. 
Estimation of an active ingredient in bulk and in tablet dosage 
form (Formulation analysis) Twenty tablets (capeguard 500 mg) were weighed accurately and crushed into powder form. Accurately weighed the quantity of powder taken and a standard solution of 1000 µg/ml was prepared using the mobile phase and the diluting fluid. Serial dilutions were taken to ensure the standard solution prepared, and the solutions were analyzed spectrophotometrically and chromatographically using the proposed methods.  
RESULTS AND DISCUSSION 
Linearity and range The linearity of CPTB employing UV method was constructed by considering concentration (µg/ml) on X–axis and Absorbance on Y–
axis. The regression coefficient was considered to be 0.999 over a concentration range of 2–20 µg/ml. The representative linearity 
equation was found to be y = 0.0256x+0.0002 as showed in fig. 2 and data were shown in table 3.  The linearity of proposed CPTB employing HPLC method was constructed by considering concentration (µg/ml) on X–axis and peak area on Y-axis. The regression coefficient was considered to be 0.999 over a concentration range of 2–100 µg/ml. The representative linearity 
equation was found to be y = 57534x+17091 as showed in fig. 3 and the corresponding data were shown in table 3. For both the methods the % RSD was found to be within the acceptable theoretical limits of ≤ 2%. 
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Table 2: Summary of validation parameters obtained for proposed UV and HPLC methods 
Validation parameters UV HPLC Beer's law limit 2-20 2-100 Correlation coefficient (r2) 0.999 0.999 Regression equation Y = 0.025x+0.000 y = 57283x+37336 Slope 0.025 57283 Intercept 0.000 37336 LOD 0.234 0.097 
LOQ 0.710 0.294 
 
Table 3: Linearity data table for proposed HPLC and UV methods (where n=6) 
HPLC linearity data UV linearity data 
Concentration (mcg/ml) Peak area±RSD Concentration (mcg/ml) Absorbance 2 158716±639.22 2 0.049±0.005 
4 262784±12119.81 4 0.106±0.011 
6 425330±2064.75 6 0.158±0.006 8 528899±66248.83 8 0.207±0.002 10 638175±1820.09 10 0.258±0.006 20 1167819±60367.12 12 0.303±0.002 
40 2266267±100287.5 14 0.355±0.006 
60 3468807±374512.7 16 0.415±0.008 80 4496095±3019.35 18 0.463±0.013 100 5885228±139667 20 0.514±0.011 Correlation coefficient 0.999 Correlation coefficient 0.999 Slope 57300 Slope 0.025 Intercept 35375 Intercept 0.000 
 
 
Fig. 1: UV visible spectrum scan of CPTB in water and methanol 
 
 
Fig. 2: Linearity curve of CPTB obtained from UV method 
 
Precision The % RSD for intra-day precision (six independent series in the same day) and inter-day precision (3 consecutive days) analysis 
performed for six different individual samples of drug solution using 
the proposed UV and HPLC methods was found to be 0.021%, 0.72% 
and 0.39%, 0.91% respectively. Since the values obtained as shown in table 4 were within the proposed theoretical limits<2% RSD according to IP, the method was demonstrated to be precise. 
 
 
Fig. 3: Linearity curve of CPTB obtained from HPLC method 
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 Table 4: Precision analysis data of CPTB for UV and HPLC 
Parameter UV HPLC Interday (% RSD) 0.021 0.39 Intraday (% RSD) 0.72 0.91 
 
Recovery studies The accuracy of the proposed UV-visible spectroscopic method and 
HPLC method was established by recovery experiments. The recovery analysis studies were carried out at three different 
concentration ranges (50, 100 and 150%). All studies were carried in triplicate, and the results obtained were presented in table 5. The analyzed samples yielded high recovery values from the proposed methods. % RSD values were found to be less than 0.2% for both UV and HPLC analysis, indicating that the proposed methods were accurate. All the RSD values obtained were less than the theoretical limit of<2% RSD according to IP. F-test results for both the UV and HPLC methods revealed that the Fcal value is less than the Ftabulated value as shown in table 6 & 7, proving that null hypothesis is accepted. Hence it was proved that there is no significant difference between the actual amount added, and the amount recovered. 
 
Table 5: Recovery analysis for CPTB by the proposed UV and HPLC methods 
Method Concentration 
level 
Amount added 
(µg/ml) 
Total amount 
(µg/ml) 
Amount found 
(µg/ml) 
Amount recovered 
(µg/ml) 
% 
recovery  
% 
RSD 
 UV 50 5 15 14.97 4.97 99.4 0.054 100 10 20 19.73 9.81 98.1 0.063 150 15 25 24.82 14.78 98.53 0.059 
 HPLC 50 5 15 14.94 4.94 98.8 0.108 100 10 20 19.73 9.73 97.3 0.038 150 15 25 24.82 14.82 98.8 0.092 
 
Table 6: Single factor ANOVA for recovery studies performed using UV method 
Source of variation SS df MS F cal P-value F tab Between Groups 0.032266667 1 0.032267 0.001315 0.972806 7.708647 Within Groups 98.12086667 4 24.53022    
 
Table 7: Single factor ANOVA for recovery studies performed using HPLC method 
Source of variation SS Df MS F cal P-value F tab Between Groups 0.04335 1 0.04335 0.001755 0.968595 7.708647 Within Groups 98.8222 4 24.70555    
 
Robustness  The robustness of the proposed HPLC method was checked in terms of variation in mobile phase, flow rate change and 
wavelength change. Experimental findings proved that the change of mobile phase is the most influential factor on repeatability of the proposed HPLC method. Suitable measures have been adopted to maintain similarity in various instrumental aspects like injection and capillary conditioning. Since % RSD values for all the parameters were found to be less than 0.1% (less than the acceptable theoretical limit of<2% RSD) the proposed HPLC 
method was found to be robust. The results obtained were presented in table 8.  The robustness of the proposed UV method was checked in terms of 
variation in mobile phase and change in wavelength. Experimental findings proved that change in the mobile phase has a higher influence on repeatability of the proposed UV method compared to change in wavelength. % RSD values for all the parameters were found to be less than 0.02% (less than the acceptable theoretical limit of<2% RSD) which proved that the proposed UV method was found to be robust. The results obtained were presented in table 9.  
Table 8: Results obtained for robustness study of HPLC method (n=6) 
S. No. Parameter Condition Area±RSD % of change 1 Standard solution (60 mcg) Standard condition 3468807 ---- 2 Mobile phase change Methanol: acetonitrile: water 28: 32: 80 3223986±1023.47 0.071 
Methanol: acetonitrile: water 30: 28: 78 3733627±1945.68 0.076 
3 Flow change 0.9 ml/min 3592787±2012.63 0.036 1.1 ml/min 3686436±1897.13 0.063 
4 Wavelength change 302 nm 3492661±1895.85 0.007 
306 nm 3447989±2147.58 0.006  
Table 9: Results obtained for robustness study of UV-visible spectrophotometric method (n = 6) 
S. No. Parameter Condition Absorbance (nm) % of change 1 Standard solution (10 mcg) Standard condition 0.258±0.017 ---- 2 Mobile phase change Distilled water: methanol (98: 2) 0.261±0.047 0.0114 Distilled water: methanol (97: 3) 0.262±0.053 0.0153 
3 Wavelength change 302 nm 0.256±0.068 0.007 
306 nm 0.259±0.038 0.004  
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Ruggedness Standard solutions of CPTB were analyzed using both the proposed methods for ruggedness.  The results showed that there is not any significant statistical difference between labs, analysts or between instruments. Thus both the methods are proven to have ruggedness. 
Detection and quantification limits 
The LOD and LOQ for CPTB utilizing the proposed UV method were 
determined to be 0.234 µg/ml and 0.710 µg/ml respectively.  
The LOD and LOQ for CPTB using the proposed HPLC method were 
found to be 0.0969µg/ml and 0.2936µg/ml respectively. The results obtained were presented in table 2. 
Both the methods indicate the accuracy and precision to detect a 
very low quantity of analyte which is a favorable sign for extending the method to plasma drug analysis. 
Specificity The selectivity and specificity of the proposed methods were tested by studying the effect of various excipients and other additives usually present in the formulations of cCPTB. The chromatograms didn’t yield any peaks for mobile phase and placebo when analyzed with the proposed HPLC method. No absorbance was found for blank/dilution fluid when analyzed spectrophotometrically using the proposed UV method. The results obtained were presented in table 10. The well-shaped peaks and the linearity of the results indicate that the proposed methods are selective and specific. A model chromatogram was illustrated in fig. 4.  
Table 10: Selectivity and specificity of CPTB samples using proposed UV and HPLC methods 
 Mobile phase/Dilution liquid Placebo CPTB sample  
Peak area/Absorbance UV method No absorbance No absorbance 0.258 HPLC method No peak No peak 638125  
 
Fig. 4: Typical chromatogram of CPTB  
Table 11: Formulation analysis results 
S. No. Tablet name Dose Sample concentration Sample estimated % of drug estimated in tablet 1 CAPEGUARD (UV) 500 mg 1 mg/ml 0.99±0.0002 mg/ml 99.0 % 2 CAPEGUARD (HPLC) 500 mg 5 mg/ml 4.98±0.0001 mg/ml 99.7%  
Determination of an active ingredient in bulk and in tablet 
dosage form (Formulation analysis) Twenty solutions of CPTB were prepared using bulk drug and tablet dosage form (capegaurd). The samples were analyzed with both the 
proposed methods using the same experimental conditions and the drug content was found to be within the limits specified by I. P. The results obtained were presented in table 11.  F-test results for UV and HPLC method revealed that the Fcal value<Ftab value proving that null hypothesis is accepted. Hence it was proved that in both the methods, there is no significant difference between sample concentration and the sample estimated. The results also assured that both the proposed methods are selective for estimation of formulations. 
CONCLUSION A novel, precise, economical, accessible, reliable and reproducible method for estimation of CPTB in bulk and tablet dosage form using UV and HPLC methods were developed and were validated according to ICH guidelines. The wide range of linearity and use of readily available and economical mobile phase and dilution fluids establishes a further scope of promoting the proposed methods for estimation of capecitabine. The RSD values for all the validation parameters were found to be less than 1, indicating that the proposed UV and HPLC methods were trusts worthy. Both the methods have ample scope and application in industry for estimation of CPTB. 
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